Spero Therapeutics, Inc.
NASDAQ:SPRO
1.37 (USD) • At close September 13, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | 2018 Q4 | 2018 Q3 | 2018 Q2 | 2018 Q1 | 2017 Q4 | 2017 Q3 | 2017 Q2 | 2017 Q1 | 2016 Q4 | 2016 Q3 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 6.017 | 4.204 | 71.827 | 25.473 | 0.788 | 0.74 | 46.302 | 1.082 | 0.896 | 0.247 | 2.744 | 3.064 | 5.148 | 7.3 | 1.907 | 3.995 | 1.727 | 0.169 | 0.696 | 0.172 | 2.156 | 3.807 | 1.692 | 0.658 | 0.463 | 1.153 | 0.993 | 0.597 | 0.249 | 0.14 | 0.335 | 0 |
| Cost of Revenue
| 0.002 | -5.063 | 0.038 | 0.108 | 9.51 | 8.979 | 0.361 | 0.485 | 8.173 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit
| 6.015 | 9.267 | 71.789 | 25.365 | -8.722 | -8.239 | 45.941 | 0.597 | -7.277 | 0.247 | 2.744 | 3.064 | 5.148 | 7.3 | 1.907 | 3.995 | 1.727 | 0.169 | 0.696 | 0.172 | 2.156 | 3.807 | 1.692 | 0.658 | 0.463 | 1.153 | 0.993 | 0.597 | 0.249 | 0.14 | 0.335 | 0 |
| Gross Profit Ratio
| 1 | 2.204 | 0.999 | 0.996 | -11.069 | -11.134 | 0.992 | 0.552 | -8.122 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 |
| Reseach & Development Expenses
| 23.723 | 17.332 | 16.52 | 16.393 | 9.51 | 8.979 | 15.089 | 7.36 | 8.173 | 16.971 | 17.225 | 14.436 | 14.461 | 18.404 | 13.205 | 17.706 | 15.656 | 20.436 | 25.728 | 18.495 | 12.026 | 9.526 | 9.127 | 8.459 | 7.374 | 8.925 | 12.503 | 6.91 | 7.457 | 5.999 | 6.927 | 6.005 |
| General & Administrative Expenses
| 5.533 | 5.917 | 6.433 | 5.708 | 6.096 | 7.317 | 6.495 | 6.632 | 8.051 | 15.305 | 13.021 | 11.152 | 9.229 | 8.299 | 7.498 | 5.309 | 4.547 | 4.086 | 3.785 | 4.133 | 3.782 | 3.888 | 3.649 | 3.134 | 3.06 | 3.044 | 2.49 | 3.653 | 2.957 | 1.74 | 2.218 | 1.909 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 5.533 | 5.917 | 6.433 | 5.708 | 6.096 | 7.317 | 6.495 | 6.632 | 8.051 | 15.305 | 13.021 | 11.152 | 9.229 | 8.299 | 7.498 | 5.309 | 4.547 | 4.086 | 3.785 | 4.133 | 3.782 | 3.888 | 3.649 | 3.134 | 3.06 | 3.044 | 2.49 | 3.653 | 2.957 | 1.74 | 2.218 | 1.909 |
| Other Expenses
| 0.001 | -0.014 | 0.003 | 5.306 | -0.006 | -1.329 | -1.087 | -0.924 | -0.01 | -1.822 | -0.078 | -0.087 | -0.112 | -0.118 | 0.211 | 0.055 | 0.889 | -0.674 | 0.674 | 0 | 0 | 0 | 0.485 | 0 | 0 | 0 | -0.77 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 29.256 | 23.249 | 22.953 | 27.407 | 13.678 | 14.967 | 20.497 | 13.068 | 15.127 | 30.454 | 30.246 | 25.588 | 23.69 | 26.703 | 20.703 | 23.015 | 20.203 | 22.99 | 26.579 | 18.157 | 15.808 | 9.503 | 11.084 | 10.935 | 9.971 | 10.816 | 14 | 9.966 | 10.165 | 7.599 | 9.145 | 7.914 |
| Operating Income
| -23.241 | -19.045 | 48.836 | -1.934 | -12.89 | -14.227 | 25.924 | -11.834 | -26.08 | -30.207 | -27.502 | -22.524 | -18.542 | -19.403 | -18.796 | -19.02 | -18.476 | -22.821 | -25.883 | -17.985 | -13.652 | -5.696 | -11.084 | -10.935 | -9.971 | -10.816 | -14 | -9.966 | -10.165 | -7.599 | -8.81 | -7.914 |
| Operating Income Ratio
| -3.863 | -4.53 | 0.68 | -0.076 | -16.358 | -19.226 | 0.56 | -10.937 | -29.107 | -122.296 | -10.023 | -7.351 | -3.602 | -2.658 | -9.856 | -4.761 | -10.698 | -135.036 | -37.188 | -104.564 | -6.332 | -1.496 | -6.551 | -16.619 | -21.536 | -9.381 | -14.099 | -16.693 | -40.823 | -54.279 | -26.299 | 0 |
| Total Other Income Expenses Net
| 5.379 | 6.376 | 2.743 | 0.94 | -0.006 | 0.961 | 0.847 | 0.159 | -14.445 | -2.622 | 0.126 | -0.087 | -0.112 | -0.118 | 0.211 | 0.055 | 0.889 | -0.674 | 0.674 | 0.268 | 0.502 | 0.624 | 0.485 | 0.472 | 0.015 | 0.172 | -0.77 | -0.002 | 0.35 | 1.199 | 0.617 | -0.004 |
| Income Before Tax
| -17.862 | -12.669 | 51.579 | -0.994 | -11.914 | -13.266 | 26.771 | -11.675 | -28.682 | -32.829 | -29.24 | -22.521 | -18.572 | -19.423 | -18.585 | -18.936 | -17.501 | -23.258 | -25.209 | -17.717 | -13.15 | -5.072 | -10.599 | -10.463 | -9.956 | -10.644 | -14.77 | -9.844 | -9.763 | -6.411 | -8.197 | -7.918 |
| Income Before Tax Ratio
| -2.969 | -3.014 | 0.718 | -0.039 | -15.119 | -17.927 | 0.578 | -10.79 | -32.011 | -132.911 | -10.656 | -7.35 | -3.608 | -2.661 | -9.746 | -4.74 | -10.134 | -137.621 | -36.22 | -103.006 | -6.099 | -1.332 | -6.264 | -15.901 | -21.503 | -9.232 | -14.874 | -16.489 | -39.209 | -45.793 | -24.469 | 0 |
| Income Tax Expense
| 0 | -0.092 | 0.387 | -2.211 | -0.006 | -0.961 | 0.002 | -0.159 | 0.107 | 2.622 | 1.94 | -0.09 | -0.082 | -0.098 | -0.191 | -0.029 | -0.086 | -0.237 | 0.111 | 0 | 0 | 0 | -0.139 | 0 | 0 | 0 | 1.137 | -0.13 | -0.996 | -0.524 | -1.599 | -1.598 |
| Net Income
| -17.862 | -12.669 | 51.191 | -3.205 | -11.914 | -12.305 | 26.771 | -11.516 | -28.682 | -35.451 | -29.24 | -22.521 | -18.572 | -19.423 | -18.585 | -18.936 | -17.501 | -23.258 | -25.209 | -17.717 | -13.15 | -5.072 | -10.599 | -10.463 | -9.956 | -10.644 | -14.77 | -9.836 | -9.169 | -5.876 | -7.211 | -6.316 |
| Net Income Ratio
| -2.969 | -3.014 | 0.713 | -0.126 | -15.119 | -16.628 | 0.578 | -10.643 | -32.011 | -143.526 | -10.656 | -7.35 | -3.608 | -2.661 | -9.746 | -4.74 | -10.134 | -137.621 | -36.22 | -103.006 | -6.099 | -1.332 | -6.264 | -15.901 | -21.503 | -9.232 | -14.874 | -16.476 | -36.823 | -41.971 | -21.525 | 0 |
| EPS
| -0.33 | -0.24 | 0.97 | -0.061 | -0.23 | -0.23 | 0.55 | -0.32 | -0.87 | -1.09 | -0.91 | -0.7 | -0.63 | -0.66 | -0.68 | -0.86 | -0.85 | -1.19 | -1.32 | -0.95 | -0.74 | -0.29 | -0.6 | -0.6 | -0.69 | -0.74 | -1.59 | -0.73 | -1.39 | -0.89 | -1.09 | -0.96 |
| EPS Diluted
| -0.33 | -0.24 | 0.96 | -0.061 | -0.23 | -0.23 | 0.55 | -0.32 | -0.87 | -1.09 | -0.91 | -0.7 | -0.63 | -0.66 | -0.68 | -0.86 | -0.85 | -1.19 | -1.32 | -0.95 | -0.74 | -0.29 | -0.6 | -0.6 | -0.69 | -0.74 | -1.59 | -0.73 | -1.39 | -0.89 | -1.09 | -0.96 |
| EBITDA
| -23.239 | -19.045 | 48.874 | -1.934 | -11.806 | -13.153 | 25.79 | -11.544 | -13.836 | -29.959 | -27.156 | -22.376 | -18.394 | -19.244 | -18.796 | -18.829 | -18.286 | -22.632 | -25.883 | -17.496 | -13.464 | -5.512 | -11.084 | -10.854 | -9.877 | -10.721 | -14 | -9.87 | -10.432 | -7.512 | -9.342 | -7.836 |
| EBITDA Ratio
| -3.862 | -4.53 | 0.68 | -0.076 | -14.982 | -17.774 | 0.557 | -10.669 | -15.442 | -121.291 | -9.897 | -7.303 | -3.573 | -2.636 | -9.856 | -4.713 | -10.588 | -133.917 | -37.188 | -101.721 | -6.245 | -1.448 | -6.551 | -16.495 | -21.333 | -9.298 | -14.099 | -16.533 | -41.896 | -53.657 | -27.887 | 0 |